ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Jing LuoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingObesity & Overweight | Cardiometabolic Health IndicatorsUnited States
-
National Institute of Arthritis and Musculoskeletal...RecruitingArthritis | Rheumatic Diseases | Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Spondylarthritis | Sjogren's Syndrome | Lupus Vasculitis, Central Nervous System | Ankylosing SpondylarthritisUnited States
-
M.D. Anderson Cancer CenterRecruitingLBCL | Comprehensive Genomic | Precision TreatmentUnited States
-
National Institute of Allergy and Infectious Diseases...Not yet recruitingMalaria | Healthy VolunteerUnited States
-
Hospices Civils de LyonIPHYMNot yet recruitingJoint Pain | Adjuvant Treatment | Symptom Management | Hormone Therapy-induced Arthralgia | Phytotherapy | Patient AcceptabilityFrance
-
The First Hospital of Jilin UniversityRecruitingPain Management | Respiration; Sleep Disorder | Overweight , ObesityChina
-
Dokuz Eylul UniversityRecruitingAnxiety | Open Heart Surgery | Pain and Anxiety | Pain After Surgery | Anxiety After SurgeryTurkey (Türkiye)
-
Shihezi UniversityThe General Hospital of the Eighth Division (The Third Affiliated Hospital...Not yet recruiting
-
Amasya UniversityNot yet recruitingUniversity StudentsTurkey (Türkiye)
-
CelgeneRecruiting
-
Transcend TherapeuticsRecruitingPost Traumatic Stress DisorderUnited States
-
National University of SingaporeKHANA Center for Population Health ResearchRecruiting
Clinical Research Jobs
-
India - Navi Mumbai
-
Netherlands
-
China
-
United States - North Carolina - Durham
-
India - Karnataka - Bengaluru
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China